Related Experiment Video
Updated: Nov 29, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
Stem cell-derived exosomes: Role in the pathogenesis and treatment of atherosclerosis
Hao Ling1, Ziyuan Guo1, Linlin Tan1
1Department of Cardiology, Second Hospital of Jilin University, Chang Chun, 130012, China.
Insights
Atherosclerosis (AS) is a chronic inflammatory vascular disease. This review explores how stem cell-derived exosomes can offer novel therapeutic strategies for treating AS, improving clinical outcomes.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Nanomedicine
Background:
- Atherosclerosis (AS) is a chronic inflammatory vascular disease with high morbidity and mortality.
- Current AS therapies are insufficient, necessitating novel treatment approaches.
- Exosomes, particularly those derived from stem cells, show potential in regulating AS progression.
Purpose of the Study:
- To review the pathological mechanisms of Atherosclerosis (AS).
- To discuss the role of exosomes and stem cell-derived exosomes in AS.
- To propose novel therapeutic strategies for AS using stem cell-derived exosomes.
Main Methods:
- Literature review of Atherosclerosis (AS) pathology.
- Analysis of exosome and stem cell-derived exosome functions in AS.
- Synthesis of current research to propose therapeutic strategies.
Main Results:
- AS involves complex processes including endothelial dysfunction, inflammation, smooth muscle cell proliferation, and macrophage activation.
- Exosomes play a role in various AS processes.
- Stem cell-derived exosomes demonstrate potential to overcome limitations in AS and stem cell therapy.
Conclusions:
- Stem cell-derived exosomes represent a promising therapeutic avenue for Atherosclerosis (AS).
- Further research into stem cell-derived exosomes could significantly improve clinical AS treatment.
- Targeting AS with exosomes offers a novel strategy for managing this complex vascular disease.
Abstract:
Atherosclerosis (AS) is a chronic inflammatory vascular disease characterized by the accumulation of lipids and inflammatory debris in large arteries, high morbidity, and AS-related disease mortality. AS is a complex process, involving endothelial cell dysfunction and inflammation, smooth muscle cell proliferation, and macrophage activation. However, the currently available therapies for AS are not ideal, thus requiring development of novel treatment strategies. Exosomes are bi-lipid membranous extracellular containing multifarious cargo, such as proteins, lipids, micro ribonucleic acid (miRNAs), messenger RNAs, and long non-coding RNAs. Moreover, exosomes reportedly participate in various AS processes. Specifically, stem cell-derived exosomes can regulate the occurrence and development of AS, exhibiting the ability to overcome the limitations associated with AS treatment and stem cell therapy. In this paper, we review the pathological mechanism of AS and discuss the role of exosomes and stem cell-derived exosomes in AS progression. We conclude by suggesting new therapeutic strategies for treating AS with stem cell-derived exosomes in the hope of improving the clinical treatment of AS.
More Related Videos
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
04:54Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Mesenchymal Stem Cells
Clinical Applications of Epidermal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Atherosclerosis I: Introduction
Regulation of Hematopoietic Stem Cells